Your search returned 45 results.

Sort
Results
1.
Targeted Glycemic Control for Adult Patients with Type 2 Diabetes Mellitus in the Acute Care Setting. [Review] MedStar authors:
  • Mazer-Amirshahi, Maryann
PMID:
  • 29807752
Year: 2018
Citation:
  • Canadian Journal of Diabetes. 42(6):671-677, 2018 Dec.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Emergency Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Caggiula A, Johnson S, Mazer-Amirshahi M, Nawab A, Payette C, Pourmand A
2.
Insulin and Its Cardiovascular Effects: What Is the Current Evidence?. [Review] MedStar authors:
  • Dongerkery, Sahana Pai
  • Schroeder, Pamela R
  • Shomali, Mansur E
PMID:
  • 29058131
Year: 2017
Citation:
  • Current Diabetes Reports. 17(12):120, 2017 Oct 23
Institution:
  • MedStar Union Memorial Hospital
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Dongerkery SP, Schroeder PR, Shomali ME
3.
Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 33468520
Year: 2021
Citation:
  • Diabetes Care. 44(3):774-780, 2021 03.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Birkenfeld AL, Blonde L, Del Prato S, Frias J, Ji C, Niemoeller E, Rosenstock J, Souhami E
4.
Evaluating the potential benefits of metformin in patients with cardiovascular disease and heart failure. MedStar authors:
  • Amin, Shril M
  • Chilipko, Allison A
  • Macharia, David
  • Norwood, Daryn K
  • Still, Kimberly L
PMID:
  • 24007890
Year: 2013
Citation:
  • Consultant Pharmacist. 28(9):579-83, 2013 Sep.
Institution:
  • MedStar Union Memorial Hospital
Department:
  • Pharmacy
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Amin SM, Chilipko AA, Macharia D, Norwood DK, Still KL
5.
Differences in complications, cardiovascular risk factor, and diabetes management among participants enrolled at veterans affairs (VA) and non-VA medical centers in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE). MedStar authors:
  • Aroda, Vanita R
  • Park, Jean
PMID:
  • 34971663
Year: 2022
Citation:
  • Diabetes Research & Clinical Practice. 184:109188, 2022 Feb.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Florez HJ, Ghosh A, GRADE Research Group, Hox SH, Killean T, Krause-Steinrauf H, McKee MD, Park J, Pop-Busui R, Rhee MK, Underkofler C, Wexler DJ
6.
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31189519
Year: 2019
Citation:
  • The Lancet Diabetes & Endocrinology. 7(8):596-605, 2019 08.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Gonzalez-Galvez G, Gron R, Halladin N, Haluzik M, Jermendy G, Kok A, Orsy P, Sabbah M, Sesti G, Silver R
7.
Stent thrombosis is not increased following percutaneous coronary intervention in patients with non-insulin dependent diabetes mellitus taking metformin. MedStar authors:
  • Chen, Fang
  • Lipinski, Michael J
  • Pendyala, Lakshmana K
  • Torguson, Rebecca
  • Waksman, Ron
PMID:
  • 24908239
Citation:
  • Atherosclerosis. 235(2):295-8, 2014 Aug.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Observational Study
Form of publication:
  • Journal Article
All authors:
  • Chen F, Lipinski MJ, Pendyala LK, Torguson R, Waksman R
8.
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program. [Review] MedStar authors:
  • Aroda, Vanita R
  • Peng, Hui
  • Want, Laura L
PMID:
  • 27037706
Year: 2016
Citation:
  • Current Diabetes Reports. 16(5):44, 2016 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Peng H, Want LL
9.
Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale. [Review] MedStar authors:
  • Aroda, Vanita R
  • Yassin, Sayf A
PMID:
  • 28356718
Year: 2017
Citation:
  • Drug design, development & therapy. 11:923-937, 2017
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Yassin SA
10.
Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31025878
Year: 2019
Citation:
  • Diabetes Technology & Therapeutics. 21(5):273-285, 2019 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Bergenstal RM, Brazg RL, Calibra Study Group, Dreon DM, Frias JP, Johnson ML, Klonoff DC, Kruger DF, Levy BL, Naik RG, Peyrot M, Ramtoola S, Rosenstock J, Serusclat P, Shearer DM, Weinstock RS, Zraick V
11.
Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?. [Review] MedStar authors:
  • Aroda, Vanita R
  • Ghazi, Adline
  • Kuhn, Alexander
  • Park, Jean
PMID:
  • 28251513
Year: 2017
Citation:
  • Current Cardiology Reports. 19(3):25, 2017 Mar
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Ghazi A, Kuhn A, Park J
12.
Access to Care and Diabetes Management Among Older American Indians With Type 2 Diabetes. MedStar authors:
  • Howard, Barbara V
PMID:
  • 26944805
Year: 2016
Citation:
  • Journal of Aging & Health. 29(2):206-221, 2017 Mar
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Howard BV, Manson SM, Nicklett EJ, Omidpanah A, Whitener R
13.
Cardiovascular Protection by Metformin: Latest Advances in Basic and Clinical Research. [Review] MedStar authors:
  • Li, Jason
PMID:
  • 37307806
Year: 2023
Citation:
  • Cardiology. 148(4):374-384, 2023.
Department:
  • Internal Medicine Residency Z
  • MedStar Georgetown University Hospital/MedStar Washington Hospital Center
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Li JZ, Li YR
14.
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28344112
Year: 2017
Citation:
  • The Lancet Diabetes & Endocrinology. 5(5):355-366, 2017 May
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Axelsen M, Bain SC, Cariou B, DeVries JH, Piletic M, Rose L, Rowe E
15.
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29397376
Year: 2018
Citation:
  • The Lancet Diabetes & Endocrinology. 6(4):275-286, 2018 04.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Andreassen C, Aroda VR, Lingvay I, Ludemann J, Navarria A, Pratley RE, SUSTAIN 7 investigators, Viljoen A
16.
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31186300
Year: 2019
Citation:
  • Diabetes Care. 42(9):1724-1732, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Altuntas Y, Aroda VR, Christiansen E, Haluzik M, Hertz CL, Jeppesen OK, Lalic NM, Morales Villegas EC, PIONEER 1 Investigators, Rosenstock J, Terauchi Y
17.
Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan: A Randomized Controlled Trial. MedStar authors:
  • Zaghlol, Raja
PMID:
  • 34305809
Year: 2021
Citation:
  • Frontiers in Endocrinology. 12:613826, 2021.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Internal Medicine Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Amarin JZ, Beirat AF, Hasan YY, Hassoun Al Najar AM, Qtaishat A, Tierney ME, Zaghlol LY, Zaghlol RY, Zayed AA
18.
A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women's Health Initiative Dietary Modification Trial. MedStar authors:
  • Howard, Barbara V
PMID:
  • 29282203
Year: 2017
Citation:
  • Diabetes Care. 41(4):680-687, 2018 04.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Allison M, Aragaki AK, Hingle MD, Howard BV, Johnson KC, Manson JE, Prentice RL, Shadyab AH, Shikany JM, Snetselaar LG, Thomson CA, Tinker LF, Zaslavsky O
19.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27284114
Year: 2016
Citation:
  • Diabetes Care. 39(9):1579-86, 2016 Sep
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
20.
Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors:
  • Weissman, Neil J
PMID:
  • 27888609
Year: 2017
Citation:
  • Obesity. 25(1):39-44, 2017 Jan
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ
21.
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. MedStar authors:
  • Ratner, Robert E
PMID:
  • 24705615
Year: 2014
Citation:
  • Diabetes Care. 37(6):1706-11, 2014 Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
22.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530667
Year: 2019
Citation:
  • Diabetes Care. 42(12):2262-2271, 2019 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
23.
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31359368
Year: 2019
Citation:
  • Advances in Therapy. 36(9):2310-2326, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Blonde L, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M
24.
Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction. [Review] MedStar authors:
  • Lam, Phillip H
  • Patel, Jay
  • Rassekh, Negin
  • Sheikh, Farooq H
PMID:
  • 37254024
Year: 2023
Citation:
  • Drugs. 83(9):747-759, 2023 Jun.
Institution:
  • MedStar Heart & Vascular Institute
  • MedStar Washington Hospital Center
Department:
  • Cardiovascular Disease Fellowship
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Ahmed A, Deedwania P, Fonarow GC, Lam PH, Patel J, Rassekh N, Sheikh FH
25.
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386990
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
26.
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
  • Ratner, Robert E
PMID:
  • 24650952
Year: 2014
Citation:
  • Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
27.
Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. MedStar authors:
  • Weintraub, William S
PMID:
  • 31023428
Year: 2019
Citation:
  • Journal of the American College of Cardiology. 73(16):2049-2058, 2019 04 30.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Berman DS, Boden WE, COURAGE Trial Research Group, Hartigan PM, Kostuk WJ, Mancini GBJ, Maron DJ, Spertus JA, Teo KK, Weintraub WS
28.
An update on pharmacotherapies in diabetic dyslipidemia. [Review] MedStar authors:
  • Ghosh, Raktim K
PMID:
  • 31442512
Year: 2019
Citation:
  • Progress in Cardiovascular Diseases. 62(4):334-341, 2019 Jul - Aug.
Institution:
  • MedStar Union Memorial Hospital
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Bandyopadhyay D, Blumenthal C, Deedwania P, Ghosh RK, Gupta M, Philip K, Tummala R, Ventura H
29.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 27650977
Year: 2016
Citation:
  • Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
30.
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors:
  • Aroda, Vanita R
PMID:
  • 26990378
Year: 2016
Citation:
  • Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J
31.
Synergy to reduce emergency department visits for uncontrolled hyperglycemia. MedStar authors:
  • Dubin, Jeffrey S
  • Fokar, Ali
  • Magee, Michelle F
  • Nassar, Carine M
  • Sharretts, John M
  • Smith, Mark S
PMID:
  • 23610182
Citation:
  • Diabetes Educator. 39(3):354-64, 2013 May-Jun.
Institution:
  • MedStar Diabetes Institute
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Emergency Medicine
  • Medicine/Endocrinology
  • MedStar Diabetes Institute
Medline publication type:
  • Evaluation Studies
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Copeland J, Dubin JS, Fokar A, Magee MF, Nassar CM, Sharretts JM, Smith MS
32.
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
  • Fatemi, Omid
  • Yuriditsky, Eugene
PMID:
  • 25159234
Citation:
  • American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
33.
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors:
  • Ratner, Robert E
PMID:
  • 24898300
Year: 2014
Citation:
  • Diabetes Care. 37(8):2317-25, 2014 Aug.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F
34.
Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study. MedStar authors:
  • Howard, Barbara V
  • Umans, Jason G
PMID:
  • 25583752
Citation:
  • Diabetes Care. 38(4):620-7, 2015 Apr.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Best LG, Francesconi KA, Goessler W, Gribble MO, Guallar E, Howard BV, Kuo CC, Lee E, Navas-Acien A, Umans JG
35.
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. MedStar authors:
  • Epstein, Stephen E
PMID:
  • 28869590
Year: 2017
Citation:
  • Nature Genetics. 49(10):1450-1457, 2017 Oct
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abbas S, Ahmed N, Alam DS, Anand S, Asma S, Assimes TL, Benn M, Bottinger EP, Butterworth AS, Chambers JC, CHD Exome+ Consortium, Chen P, Chen YI, Chowdhury R, Chung RH, Damrauer S, Danesh J, Di Angelantonio E, EPIC-CVD Consortium, EPIC-Interact Consortium, Epstein S, Frikke-Schmidt R, Frossard P, Guo X, Howson JMM, Hsiung CA, Hsu CC, Hung YJ, Imamura M, Imran A, Iqbal W, Jabeen S, Juang JJ, Jukema JW, Kadowaki T, Kamstrup PR, Kooner JS, Kuo JZ, Lee IT, Lee JJ, Lee WJ, Liang KW, Loos RJF, Lu Y, Maeda S, Majeed F, Malik U, Mallick NH, Mehmood K, Mehra N, Melander O, Memon A, Memon FU, Michigan Biobank, Nielsen SF, Nordestgaard BG, Orho-Melander M, Pare G, Qamar N, Quertermous T, Qureshi IH, Rader DJ, Ralhan S, Rasheed A, Rasheed SZ, Reilly M, Ripatti S, Rizvi SNH, Rotter JI, Saghir T, Saleheen D, Salomaa V, Sanghera DK, Sapkota BR, Sattar N, Shah N, Sheu WH, Small A, Smit R, Surendran P, Tai ES, Tanveer-Us-Salam, Taylor KD, Teo YY, Tikkanen E, Trindade K, Tybjaerg-Hansen A, Voight BF, Wang TD, Yamauch T, Yaqoob Z, Young R, Zhang W, Zhao W
36.
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors:
  • Weissman, Neil J
PMID:
  • 22421927
Year: 2012
Citation:
  • Obesity. 20(7):1426-36, 2012 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J
37.
The Role of the alpha Cell in the Pathogenesis of Diabetes: A World beyond the Mirror. [Review] MedStar authors:
  • Martinez, Maria Sofia
PMID:
  • 34502413
Year: 2021
Citation:
  • International Journal of Molecular Sciences. 22(17), 2021 Sep 01.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Internal Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Angarita L, Bermudez V, Cabrera de Bravo M, Cano C, Chacin M, D'Marco L, Guerrero-Wyss M, Manzano A, Martinez MS, Nava M, Olivar LC, Ortiz R, Salazar J
38.
Gestational diabetes: implications for cardiovascular health. [Review] MedStar authors:
  • Ratner, Robert E
  • Sullivan, Shannon D
  • Umans, Jason G
PMID:
  • 22037824
Year: 2012
Citation:
  • Current Diabetes Reports. 12(1):43-52, 2012 Feb.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Ratner R, Sullivan SD, Umans JG
39.
An Aggregate Biomarker Risk Score Predicts High Risk of Near-Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes). MedStar authors:
  • Epstein, Stephen E
PMID:
  • 28673897
Year: 2017
Citation:
  • Journal of the American Heart Association. 6(7), 2017 Jul 03
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brooks MM, Epstein SE, Ghasemzadeh N, Hardison R, Quyyumi AA, Sikora S, Sperling L, Vlachos H
40.
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29246950
Year: 2018
Citation:
  • Diabetes Care. 41(2):258-266, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
41.
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530665
Year: 2019
Citation:
  • Diabetes Care. 42(11):2108-2116, 2019 11.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
42.
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 32139384
Year: 2020
Citation:
  • Diabetes Care. 43(5):940-947, 2020 05.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
43.
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386912
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
44.
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors:
  • Ratner, Robert E
PMID:
  • 21359834
Year: 2012
Citation:
  • The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW
45.
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28939018
Year: 2017
Citation:
  • Journal of Diabetes & its Complications. 31(12):1719-1727, 2017 Dec.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Gourgari E, Hassanzadeh H, Shoulson I, Wilhelm EE
Pages

Powered by Koha